Hayden Homer

Animal Biosciences, Inc. operates as a pre-commercialization and bio-pharmaceutical company. The firm develops therapeutics and supplements for pets, primarily dogs, cats and horses. The company was headquartered in Boston, MA.

Life Biosciences, Inc. engages in the provision of research on aging and age-related diseases. It focuses on altered communication and inflammation, chromosomal instability, cellular senescence, loss of protoeostasis, metabolism, stem cell exhaustion, epigenetic alterations, and mitochondrial dysfunction. The company was founded by David Sinclair and Tristan Alexander Edwards in 2017 and is headquartered in Boston, MA.

Meditor Capital Management Ltd. (MCML) is an investment management firm headquartered in Berkshire, UK. The firm was founded in 1998 and is a subsidiary of Meditor Group Ltd. in Bermuda. MCML exclusively manages the Meditor Group assets through a highly concentrated portfolio of long-term equity positions.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Galilei Biosciences, Inc. is a company that has been in business for over 25 years. The company is based in Cambridge, MA. The company is at the forefront of technology, design, and quality, and they assist life science researchers around the world. The company was founded by Leonard Guarente.

Arc Bio LLC is an American company that is revolutionizing microbial detection by providing turnkey metagenomics solutions that combine a next-generation sequencing laboratory workflow with an automated bioinformatics pipeline. Arc Bio is based in an undisclosed location. The private company's Galileo™ platform empowers researchers and laboratorians to transition into the next era of infectious disease detection through an integrated set of easy-to-use, actionable genomics tools. The company aims to create a healthier world by delivering robust sample-to-report microbial profiling workflows combined with data-driven health intelligence software tools to enable a new standard of care for disease detection and monitoring. The company was founded by David Andrew Sinclair, Todd Dickinson, David Sinclair, and Carlos Bustamante. Todd Dickinson has been the CEO since incorporation.

Bold Management Partners LLC (Bold Management Partners) is a venture capital firm founded in 2015 by Peter H. Diamandis and Teymour Boutros-Ghali. The firm is headquartered in Santa Monica, California.

Alpha Wave Global (Venture Capital) is a venture capital arm of Falcon Edge Capital LP founded in 2012 by Rick Gerson, Navroz Darius Udwadia and Ryan Francis Khoury. The firm is headquartered in New York.

Tally Health is a biotechnology company that aims to increase healthspan, extend longevity, and make healthier aging accessible. The company is based in New York, NY and launches in early 2023. The company offers a proprietary diagnostic test and individualized interventions based on cutting-edge longevity research to give members science-backed tools to live healthier for longer. Join the waitlist to find out your biological age and get personalized action plans and unique daily supplements to slow cellular aging and unlock a new biological destiny. Tally Health was founded by David Andrew Sinclair and is incubated and backed by L Catterton, the largest consumer-focused private equity firm.

Delavie Sciences, LLC is an American skincare company that offers age-defying eye cream and serum formulated with Bacillus Lysate, a clinically proven ingredient that helps restore moisture to the skin and regulate visible signs of aging such as fine lines, age spots, and wrinkles. Delavie Sciences is located in the US. The private company uses Space Certified Technology™? in their products.

Trafalgar Capital Management (UK) LLP (Trafalgar UK) is an alternative investment manager headquartered in London, UK. The firm was founded by Christopher Aarons in 2001 and is wholly-owned by Trafalgar Capital Management Ltd. Trafalgar UK manages separate hedge-based strategies.

Trafalgar Capital Management (HK) Ltd. (Trafalgar HK) is a boutique investment management firm headquartered in Hong Kong. Formerly known as Megajoy Global Ltd., the firm was founded in 2010 and is owned by Trafalgar International Group SA in British Virgin Islands. Trafalgar HK manages two separate Hedge based strategies.

Continuum Biosciences, Inc. operates as a biotech company that focuses on diseases such as obesity, diabetes, and ageing. The company was founded in 2017 and is headquartered in Blacksburg, VA.

Senolytic Therapeutics, Inc. engages in healthcare service. The company was founded in 2017 and is headquartered in Chestnut Hill, MA.

Proto Axiom Pty Ltd. is an Australian company that focuses on investing in pre-clinical biotech companies to expand the growing bioscience industry. The company is based in Melbourne, Australia. The company has a disciplined and repeatable approach to investing by centralizing a world-class R & D team and licensing leading scientific IP to commercialize it. The company has an executive leadership with over 40 years of experience and a world-renowned scientific team with education from top academic institutions from across the globe, including Harvard. Despite Australia's strong biotech credentials, there is a distinct lack of early-stage venture capital funds to support and commercialize this science. The company was founded in 2021, and the CEO is Anthony Liveris.

Bell Potter Securities Ltd. (Bell Potter) is the stockbroking subsidiary of Bell Financial Group Ltd. (ASX: BFG) in Australia. The firm was created in 2001 when Bell Financial Group acquired Johnson Taylor Potter and merged them with the Bell Securities share broking business. Bell Potter is headquartered in Melbourne and offer stockbroking, portfolio management and administration, cash management, margin lending, superannuation and financial planning to private, corporate and institutional clients. Their institutional broking services are supported by a dedicated research team, a team of specialists in equity capital markets providing small, mid and large-cap corporate clients with advice, and a team of advisers across a network of offices in Australia, as well as in London and Hong Kong.

DWS Investments Australia Ltd. (DIAL) is an asset management firm headquartered in Sydney, Australia. Formerly known as Deutsche Investments Australia Ltd., the firm is a subsidiary of DWS Group GmbH & Co. KGaA, which is ultimately held by Deutsche Bank AG (ETR: DBK) in Germany. DIAL primarily performs advisory services for the US SEC-registered investment adviser RREEF America LLC (RREEF). The firm also separately manages special purpose vehicles holding equity interests in real estate assets via management investment trust structures on behalf of non-US investors.

Lux Capital Group LLC (Lux Capita Group) is a venture capital firm founded in 2000 by Peter Hebert and Josh Wolfe. The firm is headquartered in New York with an additional office in Menlo Park, California.

Segterra, Inc. engages in the development and marketing of a health and fitness analytics platform. It offers InsideTracker, which tracks and analyzes key biochemical and physiological markers and applies algorithms and scientific databases to determine personalized optimal zones for each marker. The company was founded by Richard Arnstein, Gil Blander, Christina Reich and David Lester in 2009 and is headquartered in Cambrdige, MA.

EdenRoc Sciences LLC engages in the business of biotechnology. The company was founded in 2016 and is headquartered in Birmingham, MI.

Immetas Therapeutics, Inc. develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases. The company was founded by J. Gene Wang and David A. Sinclair in October 2018 and is headquartered in East Hanover, NJ.

Part of BioAgilytix Labs LLC, 360biolabs Pty Ltd. is a specialty laboratory that supports pharmaceutical and biotech companies in various therapeutic areas. The company is based in Melbourne, Australia and is known for its world-class technical team that delivers technically challenging assays. The Australian company provides regulatory compliant assays and reports with a focus on quality, following various standards such as iso/iec 17025, iso 15189, oecd glp, gclp, and ich gcp. 360biolabs is the leading and most comprehensive specialty laboratory in the region, offering expert pharmacokinetic (pk) and pharmacodynamic (pd) assay services that support small molecule, biologic, vaccine, and other innovative therapeutic solutions to human health. The company was founded in 2015 by Simon Tucker, Alistair Draffan, Melinda Pryor, Angela Luttick, and Alistair Draffan has been the CEO of the company since January 01, 2015. 360biolabs was acquired by BioAgilytix Labs LLC from The Macfarlane Burnet Institute For Medical Research & Public on October 14, 2021.